Related Experiment Videos
[Aortic valvuloplasty in the elderly. Immediate and medium-term results]
Annales De Radiologie
|January 1, 1989
Summary
Percutaneous aortic valvuloplasty improved aortic valve area in 68% of patients. However, high morbidity and mortality rates suggest it should be reserved for non-surgical candidates.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Aortic stenosis is a significant cardiovascular condition.
- Percutaneous aortic valvuloplasty (PAV) emerged as a less invasive alternative to surgical aortic valve replacement.
Purpose:
- To evaluate the safety and efficacy of percutaneous aortic valvuloplasty (PAV) in a cohort of 100 patients.
Summary:
- PAV achieved hemodynamic success in 68% of patients, increasing aortic valve area (0.52 to 0.78 cm2). In-hospital mortality was 8% with 11% morbidity.
- Six-month follow-up showed persistent functional improvement in 68% of initially successful cases, but 27% experienced clinical failure.
- One-year actuarial survival was 74%, with 53% clinical improvement and 41% recurrence of symptoms.
Impact:
- PAV demonstrated potential for hemodynamic improvement but was associated with significant early mortality and morbidity.
- Clinical outcomes at one year highlight a substantial rate of symptom recurrence.
- The findings suggest that PAV is a viable option primarily for patients who are not candidates for traditional surgery.